Dengue in Pune city, India (2017–2019): a comprehensive analysis

Vidya Arankalle,Shubham Shrivastava,Ruta Kulkarni,Rahul Patil,Divya Tiraki,Sanjay Mankar,Rohini Mahesh Taru,Raj Lavange,Arundhati Diwan,Sanjay Lalwani,AkhileshChandra Mishra
DOI: https://doi.org/10.3389/fpubh.2024.1354510
IF: 5.2
2024-09-20
Frontiers in Public Health
Abstract:Objectives To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years. Methods During 3 dengue seasons (2017–19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) was used to differentiate primary/secondary infections. DENV serotypes were determined for 260 viral RNA-positive patients. Results During the 3 years, 3,014/6,786 (44.4%, 41.4–49.9%) suspected cases were diagnosed as dengue. Use of either NS1 or IgM would have missed 25.5% or 43% of the confirmed dengue cases, respectively. Notably, a higher proportion of secondary dengue cases remained mild while a substantial proportion of primary infections developed warning signs. The symptoms among Dengue/non-dengue patients and primary/secondary infections varied and influenced by age and serostatus. The number and proportion of dengue serotypes varied yearly. A remarkable decline in dengue cases was observed during the COVID-19 pandemic years. Conclusion A substantial proportion of primary and secondary dengue patients progress to warning signs/severity or mild infection respectively, underscoring the possible role of non-ADE mechanisms in causing severe dengue that requires hospitalization. Both NS1 and IgM should be used for efficient diagnosis.
public, environmental & occupational health
What problem does this paper attempt to address?